Target Price | $367.20 |
Price | $312.45 |
Potential |
17.52%
register free of charge
|
Number of Estimates | 27 |
27 Analysts have issued a price target Insulet Corporation 2026 .
The average Insulet Corporation target price is $367.20.
This is
17.52%
register free of charge
$420.00
34.42%
register free of charge
$303.00
3.02%
register free of charge
|
|
A rating was issued by 32 analysts: 28 Analysts recommend Insulet Corporation to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insulet Corporation stock has an average upside potential 2026 of
17.52%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.07 | 2.68 |
22.07% | 29.18% | |
EBITDA Margin | 18.81% | 22.71% |
9.03% | 20.72% | |
Net Margin | 20.19% | 12.46% |
66.11% | 38.29% |
29 Analysts have issued a sales forecast Insulet Corporation 2025 . The average Insulet Corporation sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Insulet Corporation EBITDA forecast 2025. The average Insulet Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
28 Insulet Corporation Analysts have issued a net profit forecast 2025. The average Insulet Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 5.66 | 4.74 |
102.14% | 16.25% | |
P/E | 65.95 | |
EV/Sales | 8.37 |
28 Analysts have issued a Insulet Corporation forecast for earnings per share. The average Insulet Corporation EPS is
This results in the following potential growth metrics and future valuations:
Insulet Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Sep 29 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Aug 21 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Jun 16 2025 |
Analyst Rating | Date |
---|---|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Sep 29 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Sep 08 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Aug 21 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Jun 16 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.